14.07.2022 - REDWOOD CITY, Calif., July 14, 2022 (GLOBE NEWSWIRE) - Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced that the Company has entered into an agreement with Pfizer for the .
Codexis (CDXS) Enters Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.